A detailed history of Monashee Investment Management LLC transactions in Karyopharm Therapeutics Inc. stock. As of the latest transaction made, Monashee Investment Management LLC holds 132,435 shares of KPTI stock, worth $95,353. This represents 0.01% of its overall portfolio holdings.

Number of Shares
132,435
Holding current value
$95,353
% of portfolio
0.01%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$0.7 - $1.06 $92,704 - $140,381
132,435 New
132,435 $109,000
Q4 2023

Feb 12, 2024

BUY
$0.68 - $1.31 $90,055 - $173,489
132,435 New
132,435 $113,000
Q4 2022

Feb 09, 2023

BUY
$2.48 - $5.93 $1.19 Million - $2.86 Million
481,696 New
481,696 $1.64 Million

Others Institutions Holding KPTI

About Karyopharm Therapeutics Inc.


  • Ticker KPTI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 79,806,600
  • Market Cap $57.5M
  • Description
  • Karyopharm Therapeutics Inc., a commercial-stage pharmaceutical company, discovers, develops, and commercializes drugs directed against nuclear export for the treatment of cancer and other diseases. The company discovers, develops, and commercializes novel and Selective Inhibitor of Nuclear Export (SINE) compounds function by binding with and in...
More about KPTI
Track This Portfolio

Track Monashee Investment Management LLC Portfolio

Follow Monashee Investment Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Monashee Investment Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Monashee Investment Management LLC with notifications on news.